<!DOCTYPE html>
<html lang="en">

<head>

    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="">
    <meta name="author" content="">

    <title>ALS Compendium</title>

    <!-- Bootstrap Core CSS -->
    <link href="css/bootstrap.min.css" rel="stylesheet">

    <!-- Custom CSS -->
    <link href="css/3-col-portfolio.css" rel="stylesheet">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.4.2/respond.min.js"></script>
    <![endif]-->

</head>

<body>

    <!-- Navigation -->

    <!-- Page Content -->
    <div class="container">

        <!-- Page Header -->
        <div class="row">
            <div class="col-lg-12">
                <h1 class="page-header">ALS Compendium
                </h1>

                <div class="col-md-6">
                    <img class="img-responsive img-border-left" src="./img/38.png" alt="">
                </div>
                <div class="col-md-6">
                  <p><strong>Title:</strong> Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival</p>
                  <p><strong>Year Published:</strong> 2013</p>
                  <p><strong>Observation:</strong> Enhanced exhitability can protect vulnerable alpha MNs. Activation of neuroprotection pathways in fALS motor neurons lead to elevated Brg2, which was restored to nearly normal by AMPA. Altered signaling to CREB in affected fALS mice. mTOR has a neuroprotective role</p>
                  <p><strong>Comment:</strong> Excitability and mTOR are key endogenous neuroprotection mechanisms in motoneurons to counteract clinically important disease progression in ALS.</p>
                  <p><strong>Citation:</strong> Saxena, S., Roselli, F., Singh, K., Leptien, K., Julien, J.-P., Gros-Louis, F., & Caroni, P. (2013). Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron, 80(1), 80â€“96. doi:10.1016/j.neuron.2013.07.027</p>
                  <a href="index.html">Back to Homepage</a>
                </div>
            </div>
        </div>
        <!-- /.row -->

        <!-- Projects Row -->



        <hr>

        <!-- Footer -->
        <footer>
            <div class="row">
                <div class="col-lg-12">
                    <p>Copyright &copy; ALS Compendium 2014</p>
                </div>
            </div>
            <!-- /.row -->
        </footer>

    </div>
    <!-- /.container -->

    <!-- jQuery Version 1.11.0 -->
    <script src="js/jquery-1.11.0.js"></script>

    <!-- Bootstrap Core JavaScript -->
    <script src="js/bootstrap.min.js"></script>

</body>

</html>
